Previous close | 11.32 |
Open | 11.33 |
Bid | 11.39 x 400 |
Ask | 11.45 x 200 |
Day's range | 11.22 - 11.65 |
52-week range | 10.71 - 19.40 |
Volume | |
Avg. volume | 1,807,682 |
Market cap | 3.227B |
Beta (5Y monthly) | 2.11 |
PE ratio (TTM) | 63.33 |
EPS (TTM) | 0.18 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 16.90 |
Sotera Health (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the first-quarter ended March 31, 2024 before the market opens on Thursday, May 2, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s oper
Key Insights Sotera Health's significant private equity firms ownership suggests that the key decisions are influenced...